MedTech Spectrum

Article Name Asia Pacific

Qure.ai Named to TIME’s 100 Most Influential Companies of 2025

AI-Driven Healthcare Innovator Honored for Transforming Medical Imaging and Advancing Global Access to Diagnostics

27th June, 2025

Campbell County Health to Launch Epic EHR System on July 19

New Electronic Health Record Platform Aims to Enhance Care Coordination, Patient Access, and Operational Efficiency Across the Wyoming-Based Health System

27th June, 2025

Convatec Secures U.S. FDA Approval for Subcutaneous Apomorphine Infusion Therapy

New treatment option offers continuous symptom control for patients with advanced Parkinson’s disease, enhancing quality of life through minimally invasive drug delivery

27th June, 2025

MGH and Siemens Healthineers Partner to Launch Therapy Command Center

Strategic collaboration aims to enhance real-time clinical decision-making and streamline cancer care through centralized, AI-driven support.

26th June, 2025

Femasys Secures European Approval for FemBloc®

First-Ever Non-Surgical Permanent Birth Control System Gains CE Mark, Paving the Way for a New Era in Reproductive Health

26th June, 2025

Stryker Receives FDA Clearance for InCompass™ Total Ankle System

Next-Generation Ankle Replacement Platform Designed to Improve Surgical Precision and Patient Outcomes in Orthopaedic Care

26th June, 2025

Jobizo Secures INR 12 Crore in Pre-Series A Funding

IPV and Alkemi Ventures Lead Investment to Accelerate Healthcare Workforce Platform’s Growth and Expansion

26th June, 2025

New GLP-1 Therapies Redefine Weight Loss Standards

Emerging Treatments Show Promise in Preserving Muscle Mass While Promoting Fat Reduction, Elevating the Quality of Metabolic Care

26th June, 2025

Neuspera Medical Secures FDA Approval for First-of-Its-Kind iSNM System

Breakthrough Integrated Sacral Neuromodulation Device Approved to Treat Urinary Urge Incontinence with a Minimally Invasive, Patient-Centric Approach

26th June, 2025

42 Olympus Medical Devices Face FDA Import Alert Over Quality Violations

Following multiple unresolved warnings, the U.S. FDA enforces import restrictions on 42 Olympus endoscopic devices, spotlighting persistent quality system lapses at its Aizu facility in Japan and triggering global scrutiny of manufacturing and patient safety standards.

25th June, 2025